Through improved adherence once-monthly injectable extended-release naltrexone (XR-NTX) might provide an edge over other oral agents approved for alcohol and opioid dependence treatment. sufferers relative to various other alcoholic beverages dependence realtors. Opioid reliant XR-NTX sufferers acquired lower inpatient product abuse-related usage versus other realtors and $8170 lower total price versus methadone. 1 Launch Alcohol… Continue reading Through improved adherence once-monthly injectable extended-release naltrexone (XR-NTX) might provide an